Diffusion of Technologies for the Care of Older Adults With Exudative Age-Related Macular Degeneration

Purpose: To determine patterns of diffusion of diagnostic tests and therapeutic interventions in the United States through 2010 for patients with newly diagnosed exudative macular degeneration (AMD).Design: Retrospective longitudinal cohort analysis.Methods: setting and patient population: A total of 23 941 Medicare beneficiaries with exudative AMD newly diagnosed during 1992-2009. observation procedures: Current Procedural Technology (CPT-4) billing codes were used to identify use of diagnostic tests (optical coherence tomography, fluorescein angiography, and fundus photography) and therapeutic interventions (argon laser photocoagulation, photodynamic therapy, intravitreal corticosteroids, and anti–vascular endothelial growth factor [VEGF] agents) used by these beneficiaries during the first year following diagnosis. (Read more...)

Full Story →